Preparation of the National Drug Policy, improvement of the regulatory framework governing the circulation of drugs, prospects for the introduction of drug insurance in Russia, regional experience in introducing a co-payment system, novels of the EEC single pharmaceutical market, prospects for mandatory labeling medicines and the harmonization of this process within the EurAsEC and in foreign markets will be the main topics of the XI scientific-practical conference “State regulation and the Russian pharmaceutical industry Nosta 2019: continuation of the dialogue », organized by the Association of Russian Pharmaceutical Manufacturers and the National Research Institute of Public Health named after NA Semashko.
Among the speakers of the event are heads of specialized departments, working groups of the Russian Academy of Sciences and subgroups of the State Duma Interfactional group, representatives of companies involved in the drug labeling experiment, the Association of Communication Agencies of Russia, supporters and opponents of the introduction of forced licensing in the practice of the Russian pharmaceutical market.
The event will be held April 10, 2019 at the Marriott Moscow Royal Aurora Business Hotel (11 Petrovka St., Moscow) The conference program can be found on the website http://www.arfp.ru/
Within the framework of the event, Anna Plesovskikh , Director General of the Pharmaceutical Run Interdisciplinary Association, will be the moderator of one of the sessions of the Conference.
For participation questions, please call +7 (495) 231-42-53, + 7903-529-24-99.